WallStreetZenWallStreetZen

NASDAQ: CRVS
Corvus Pharmaceuticals Inc Stock Ownership - Who owns Corvus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Corvus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
William Benton JonesSVP Pharmaceutical Development2025-06-0419,357$3.50
$67.75kBuy
Richard A. Md MillerPresident and CEO2025-05-07559,073$3.50
$1.96MBuy

1 of 1

CRVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRVS insiders and whales buy or sell their stock.

CRVS Shareholders

What type of owners hold Corvus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Peter A. Thompson9.00%6,943,654$27.01MInsider
Orbimed Advisors LLC9.00%6,943,654$27.01MInsider
Orbimed Advisors LLC9.00%6,943,654$27.01MInstitution
Ecor1 Capital LLC6.69%5,162,154$20.08MInsider
Samlyn Capital LLC5.27%4,065,935$15.82MInstitution
Terry P. Gould4.41%3,402,422$13.24MInsider
Adams Street Partners LLC4.41%3,402,422$13.24MInsider
Adams Street Partners LLC4.25%3,275,616$12.74MInstitution
Point72 Asset Management LP3.61%2,787,631$10.84MInstitution
Rtw Investments LP3.47%2,679,479$10.42MInstitution

1 of 3

CRVS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRVS47.03%39.69%Net BuyingNet Buying
LXRX22.32%77.68%Net Selling
AVIR61.87%25.34%Net Selling
ABEO41.13%58.87%Net SellingNet Selling
IVA5.08%0.00%
View Top Biotech Stocks

Corvus Pharmaceuticals Stock Ownership FAQ

Who owns Corvus Pharmaceuticals?

Corvus Pharmaceuticals (NASDAQ: CRVS) is owned by 47.03% institutional shareholders, 39.69% Corvus Pharmaceuticals insiders, and 13.27% retail investors. Peter A. Thompson is the largest individual Corvus Pharmaceuticals shareholder, owning 6.94M shares representing 9.00% of the company. Peter A. Thompson's Corvus Pharmaceuticals shares are currently valued at $27.01M.

If you're new to stock investing, here's how to buy Corvus Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.